This topic contains a solution. Click here to go to the answer

Author Question: Tiffany needs to assess the market risk in order to decide when to launch a new product. He decides ... (Read 123 times)

segrsyd

  • Hero Member
  • *****
  • Posts: 530
Tiffany needs to assess the market risk in order to decide when to launch a new product. He decides to delegate the task of risk assessment to Joe who is a competent employee of the firm. Which of the following conclusions can be drawn from this?
 a. Joe has the required tools and resources to carry out the order.
  b. Joe is above Tiffany in the hierarchy of this firm.
  c. The chances that Joe's assessment will be accurate are very high.
  d. Tiffany is well equipped to analyze the information he passes on to Joe.

Question 2

Firms in perfect competition sell differentiated products.
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tsternbergh47

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

A

Answer to Question 2

False




segrsyd

  • Member
  • Posts: 530
Reply 2 on: Jun 30, 2018
Wow, this really help


parshano

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Excellent

 

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library